Page last updated: 2024-08-21

indazoles and iniparib

indazoles has been researched along with iniparib in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Mountzios, G; Papadimitriou, CA; Papadimitriou, M1
Luger, K; Roberts, G; Rudolph, J1

Reviews

1 review(s) available for indazoles and iniparib

ArticleYear
The role of PARP inhibition in triple-negative breast cancer: Unraveling the wide spectrum of synthetic lethality.
    Cancer treatment reviews, 2018, Volume: 67

    Topics: Benzamides; Female; Genes, BRCA1; Genes, BRCA2; Homologous Recombination; Humans; Indazoles; Phthalazines; Piperazines; Piperidines; Poly(ADP-ribose) Polymerase Inhibitors; Triple Negative Breast Neoplasms

2018

Other Studies

1 other study(ies) available for indazoles and iniparib

ArticleYear
Histone Parylation factor 1 contributes to the inhibition of PARP1 by cancer drugs.
    Nature communications, 2021, 02-02, Volume: 12, Issue:1

    Topics: Antineoplastic Agents; Benzamides; Benzimidazoles; Binding Sites; Carrier Proteins; Catalysis; Catalytic Domain; DNA Repair Enzymes; Humans; Indazoles; Indoles; Nuclear Proteins; Phthalazines; Piperazines; Piperidines; Poly (ADP-Ribose) Polymerase-1; Protein Binding

2021